Biotechs Avoid Harsh Sell-Off: Many Stocks in the Green
XLE off 4%, NASDAQ Off 1.57%, Biotech Mainly In The Green After Close: Financials and Materials also hit hard down over 2% Biotech stocks remain a safe harbor in a stormy market freaked out by the energy free-fall. Most major biotech ETFs are up FBT,XBI but the IBB was a little volatile...
Happy New Year 2015!
Wishing you all a Happy and Prosperous New Year! Biotech stocks were up 47% in 2014. In 2014 the first quarter was the most volatile. Sign up now to receive all of our market and portfolio updates. In December we posted updates on our Rayno Life Science Portfolios: Rayno Diagnostics and Tools...
Rayno Dx and Tools 2014 Performance YTD: ABAX EXAS ILMN PACB SQNM
Many Big Winners Are Among Rayno Diagnostics and Tools Stocks in 2014 Abaxis (ABAX) up 46% A major “Point of Care” (POC) Dx Player in veterinary and human markets. Exact Sciences (EXAS) up 135% An emerging Dx player with non-invasive, DNA based test for colon cancer. Illumina...
Biotech Sell-Off on Abbvie (ABBV) Deal With Express Scripts: GILD Down 13%..Update-2
12/24 Technicals are holding in biotech, buyers coming in, GILD up 2.8% . Update 12/23 Second day of Sell-Off …. Caution Biotech stocks sold off hard for the second day with the “best and biggest” down 3-4%. Analyst reports were circulating about the concerns for specialty...
Sentiment Shift in a Wild Week: Biotech Bull Is Back-JUNO IPO Up 45%!… Update-1
Biotech Stocks Rally to New Highs After 4% Correction Buyers Are Bottom Feeding Energy Stocks NASDAQ at 4765 Just as the market appeared to be headed to another test of October lows, challenged by news on slowing global growth and a collapsing energy sector, FED Chair Janet Yellen calmed the...
